Literature DB >> 18988254

Prediction of antibacterial compounds by machine learning approaches.

Xue-Gang Yang1, Duan Chen, Min Wang, Ying Xue, Yu-Zong Chen.   

Abstract

The machine learning (ML) as well as quantitative structure activity relationship (QSAR) method has been explored for predicting compounds with antibacterial activities at impressive performance. It is desirable to test additional ML methods, select most representative sets of molecular descriptors, and subject the developed prediction models to rigorous evaluations. This work evaluated three ML methods, support vector classification (SVC), k-nearest neighbor (k-NN), and C4.5 decision tree, which were trained and tested by 230 antibacterial and 381 nonantibacterial compounds. A well-established feature selection method was used to select representative molecular descriptors from a larger pool than that used in reported studies. The performance of the developed prediction models was tested by 5-fold cross-validation and independent evaluation set. SVC produced the best prediction accuracies of 96.66 and 98.15% for antibacterial compounds, and 99.50 and 98.02% for nonantibacterial compounds respectively, which are slightly improved against those of the reported ML as well as QSAR models and outperform the k-NN and C4.5 decision tree models developed in this work. Our study suggests that ML methods, particularly SVC, are potentially useful for facilitating the discovery of antibacterial agents. 2008 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18988254     DOI: 10.1002/jcc.21148

Source DB:  PubMed          Journal:  J Comput Chem        ISSN: 0192-8651            Impact factor:   3.376


  5 in total

1.  Molecular dynamics simulation and conformational analysis of some catalytically active peptides.

Authors:  Bahareh Honarparvar; Adam A Skelton
Journal:  J Mol Model       Date:  2015-04-01       Impact factor: 1.810

2.  Exploring the chemical space of aromatase inhibitors.

Authors:  Chanin Nantasenamat; Hao Li; Prasit Mandi; Apilak Worachartcheewan; Teerawat Monnor; Chartchalerm Isarankura-Na-Ayudhya; Virapong Prachayasittikul
Journal:  Mol Divers       Date:  2013-07-16       Impact factor: 2.943

Review 3.  Machine Learning in Antibacterial Drug Design.

Authors:  Marko Jukič; Urban Bren
Journal:  Front Pharmacol       Date:  2022-05-03       Impact factor: 5.988

4.  Screening of antibacterial compounds with novel structure from the FDA approved drugs using machine learning methods.

Authors:  Wen-Xing Li; Xin Tong; Peng-Peng Yang; Yang Zheng; Ji-Hao Liang; Gong-Hua Li; Dahai Liu; Dao-Gang Guan; Shao-Xing Dai
Journal:  Aging (Albany NY)       Date:  2022-02-12       Impact factor: 5.682

5.  Identification of Novel Antibacterials Using Machine Learning Techniques.

Authors:  Yan A Ivanenkov; Alex Zhavoronkov; Renat S Yamidanov; Ilya A Osterman; Petr V Sergiev; Vladimir A Aladinskiy; Anastasia V Aladinskaya; Victor A Terentiev; Mark S Veselov; Andrey A Ayginin; Victor G Kartsev; Dmitry A Skvortsov; Alexey V Chemeris; Alexey Kh Baimiev; Alina A Sofronova; Alexander S Malyshev; Gleb I Filkov; Dmitry S Bezrukov; Bogdan A Zagribelnyy; Evgeny O Putin; Maria M Puchinina; Olga A Dontsova
Journal:  Front Pharmacol       Date:  2019-08-27       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.